CIK 0001035267 · Large accelerated filer
INTUITIVE SURGICAL INC
Sign in to watch- Ticker
- ISRG
- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770416458
- Phone
- 4085232100
- Business address
- 1020 KIFER ROAD, SUNNYVALE, CA, 94086
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $20,297,043
- in 15 filings, $20.3M under 10b5-1 plans
Net −$20,297,043. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- GUTHART GARY S −$13.6M Director sold 2% of stake
- Widman Fredrik −$4.6M VP Corporate Controller sold 91% of stake
- BARRATT CRAIG H −$1.0M Director sold 100% of stake
- WADORS PATRICIA L −$478K SVP Chief Human Resources Offi sold 100% of stake
- Brosius Mark −$330K EVP & Chief Mfg and Supply Cha sold 64% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-27 | Curet Myriam EVP & Chief Medical Officer | Option exercise 10b5-1 | +125 | $208.90 | $26K | 125 |
| 2026-01-27 | Curet Myriam EVP & Chief Medical Officer | Sale 10b5-1 | −125 | $532.61 | $67K | 0 |
| 2026-01-27 | Curet Myriam EVP & Chief Medical Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −125 | 251 | ||
| 2026-01-27 | Curet Myriam EVP & Chief Medical Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −105 | 1,362 | ||
| 2026-01-27 | GUTHART GARY S Director | Option exercise 10b5-1 | +25,500 | $174.26 | $4.4M | 28,194 |
| 2026-01-27 | GUTHART GARY S Director | Sale 10b5-1 | −24,500 | $530.10 | $13.0M | 3,694 |
| 2026-01-27 | GUTHART GARY S Director | Sale 10b5-1 | −1,400 | $531.53 | $744K | 15,720 |
| 2026-01-27 | GUTHART GARY S Director | Sale 10b5-1 | −1,400 | $531.52 | $744K | 15,720 |
| 2026-01-27 | GUTHART GARY S Director | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −25,500 | 0 | ||
| 2025-12-15 | Brosius Mark See Remarks | Sale 10b5-1 | −464 | $548.49 | $254K | 131 |
| 2025-12-15 | Brosius Mark SVP & Chief Mfg and Supply Cha | Sale 10b5-1 | −464 | $548.49 | $254K | 443 |
| 2025-12-12 | Brosius Mark See Remarks | Sale 10b5-1 | −312 | $547.36 | $171K | 595 |
| 2025-12-12 | Brosius Mark SVP & Chief Mfg and Supply Cha | Option exercise 10b5-1 | +4,500 | $79.64 | $358K | 5,407 |
| 2025-12-12 | Brosius Mark SVP & Chief Mfg and Supply Cha | Sale 10b5-1 | −4,500 | $547.36 | $2.5M | 907 |
| 2025-12-12 | Brosius Mark SVP & Chief Mfg and Supply Cha | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −4,500 | 0 | ||
| 2025-12-10 | Curet Myriam EVP & Chief Medical Officer | Option exercise 10b5-1 | +104 | $229.39 | $24K | 104 |
| 2025-12-10 | Curet Myriam EVP & Chief Medical Officer | Sale 10b5-1 | −104 | $559.90 | $58K | 0 |
| 2025-12-10 | Curet Myriam EVP & Chief Medical Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −104 | 1,467 | ||
| 2025-12-01 | Curet Myriam EVP & Chief Medical Officer | Option exercise 10b5-1 | +125 | $208.90 | $26K | 125 |
| 2025-12-01 | Curet Myriam EVP & Chief Medical Officer | Sale 10b5-1 | −125 | $568.99 | $71K | 0 |
Page 18 of 21 · 420 trades